315 related articles for article (PubMed ID: 28561682)
1. Advances in the Treatment of Advanced Extracutaneous Melanomas and Nonmelanoma Skin Cancers.
Komatsubara KM; Jeter J; Carvajal RD; Margolin K; Schadendorf D; Hauschild A
Am Soc Clin Oncol Educ Book; 2017; 37():641-650. PubMed ID: 28561682
[TBL] [Abstract][Full Text] [Related]
2. Non-Melanoma Skin Cancers: Biological and Clinical Features.
Cives M; Mannavola F; Lospalluti L; Sergi MC; Cazzato G; Filoni E; Cavallo F; Giudice G; Stucci LS; Porta C; Tucci M
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751327
[TBL] [Abstract][Full Text] [Related]
3. Programmed cell death 1 protein and programmed death-ligand 1 inhibitors in the treatment of nonmelanoma skin cancer: A systematic review.
Choi FD; Kraus CN; Elsensohn AN; Carley SK; Lehmer LM; Nguyen RT; Linden KG; Shiu J
J Am Acad Dermatol; 2020 Feb; 82(2):440-459. PubMed ID: 31163235
[TBL] [Abstract][Full Text] [Related]
4. The Landmark Series: Non-melanoma Skin Cancers.
Lee AY; Berman RS
Ann Surg Oncol; 2020 Jan; 27(1):22-27. PubMed ID: 31549317
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathology of skin neoplasms of the head and neck.
Kraft S; Granter SR
Arch Pathol Lab Med; 2014 Jun; 138(6):759-87. PubMed ID: 24878016
[TBL] [Abstract][Full Text] [Related]
6. PD-1 inhibition in advanced Merkel-cell carcinoma.
Baker H
Lancet Oncol; 2016 Jun; 17(6):e225. PubMed ID: 27132870
[No Abstract] [Full Text] [Related]
7. Divergent response to PD-L1 inhibition in advanced Merkel cell carcinoma and cutaneous squamous cell carcinoma.
Salzmann M; Löser C; Hassel JC
J Dtsch Dermatol Ges; 2023 Jul; 21(7):803-805. PubMed ID: 37066606
[No Abstract] [Full Text] [Related]
8. Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.
Vand-Rajabpour F; Sadeghipour N; Saee-Rad S; Fathi H; Noormohammadpour P; Yaseri M; Hesari KK; Bagherpour Z; Tabrizi M
Clin Transl Oncol; 2017 Apr; 19(4):489-497. PubMed ID: 27718152
[TBL] [Abstract][Full Text] [Related]
9. [Cytokines: current status and prospects in the treatment of skin tumors].
Nashan D; Luger TA
Hautarzt; 2001 Aug; 52(8):691-6. PubMed ID: 11544938
[TBL] [Abstract][Full Text] [Related]
10. [Cutaneous neoplasms].
Dummer R; Beyeler M; Morcinek J; Burg G
Praxis (Bern 1994); 2003 Sep; 92(36):1470-8. PubMed ID: 14526630
[TBL] [Abstract][Full Text] [Related]
11. The molecular genetics of eyelid tumors: recent advances and future directions.
Milman T; McCormick SA
Graefes Arch Clin Exp Ophthalmol; 2013 Feb; 251(2):419-33. PubMed ID: 23275038
[TBL] [Abstract][Full Text] [Related]
12. Medical management of cutaneous malignancies.
Gibbs P; Gonzalez R; Lee LA; Walsh P
Clin Dermatol; 2001; 19(3):298-304. PubMed ID: 11479042
[No Abstract] [Full Text] [Related]
13. Critical skin cancer in organ transplant recipients--a dermatopathological view.
Kempf W; Mertz KD; Kanitakis J; Hofbauer GF
Curr Probl Dermatol; 2012; 43():18-35. PubMed ID: 22377917
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for Nonmelanoma Skin Cancer: Facts and Hopes.
Shalhout SZ; Kaufman HL; Emerick KS; Miller DM
Clin Cancer Res; 2022 Jun; 28(11):2211-2220. PubMed ID: 35121622
[TBL] [Abstract][Full Text] [Related]
15. Skin cancer in organ transplant recipients.
Kempf W; Mertz KD; Hofbauer GF; Tinguely M
Pathobiology; 2013; 80(6):302-9. PubMed ID: 24013135
[TBL] [Abstract][Full Text] [Related]
16. Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810.
Falchook GS; Leidner R; Stankevich E; Piening B; Bifulco C; Lowy I; Fury MG
J Immunother Cancer; 2016; 4():70. PubMed ID: 27879972
[TBL] [Abstract][Full Text] [Related]
17. Optimal treatment of unresectable nonmelanoma skin cancers.
Olencki T
J Natl Compr Canc Netw; 2014 May; 12(5 Suppl):789-92. PubMed ID: 24853218
[TBL] [Abstract][Full Text] [Related]
18. Association of Nonmelanoma Skin Cancers, Melanoma, and Merkel Cell Carcinoma with Dermatologic Medications: A Case-Control Pharmacovigilance Study of the FDA Adverse Events Reporting System.
Jedlowski PM
Dermatology; 2023; 239(5):694-699. PubMed ID: 37054693
[TBL] [Abstract][Full Text] [Related]
19. Immunologic Characteristics of Nonmelanoma Skin Cancers: Implications for Immunotherapy.
Hall ET; Fernandez-Lopez E; Silk AW; Dummer R; Bhatia S
Am Soc Clin Oncol Educ Book; 2020 Mar; 40():1-10. PubMed ID: 32207669
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetics of melanoma and nonmelanoma skin cancer.
Carless MA; Griffiths LR
Adv Exp Med Biol; 2014; 810():160-81. PubMed ID: 25207365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
